Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cancer Ther ; 3(5): 537-44, 2004 May.
Article in English | MEDLINE | ID: mdl-15141011

ABSTRACT

OBJECTIVE: We investigated the effects of photodynamic therapy (PDT) combined with low-dose chemotherapy on breast cancer cells. Photodynamic treatment was administered by irradiating indocyanine green-preloaded MCF-7 cells with an IR diode laser source at 805 nm; cisplatin was used for chemotherapy. METHODS: The dose-response phenomena associated with the two treatments administered individually and together were evaluated with the following tests: trypan blue dye exclusion, 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bromide (MTT) assay, clonogenic survival, thymidine and methionine incorporation, and insulin-dependent and insulin-independent glucose transport. RESULTS: Viability and metabolic data demonstrated mutual reinforcement of therapeutic efficacy. However, isobolographic analysis of quantal and variable data indicated that reinforcement was additive according to trypan blue data and synergistic according to MTT data. To investigate the molecular mechanisms underlying alterations in cell proliferation and apoptosis, we evaluated (by Western blotting) the expression of proteins Bcl-2, Bax, Bcl-X(L), p21, p53, and poly(ADP-ribose) polymerase. Photodynamic treatment caused transient selective destruction of Bcl-2 and up-regulation of Bax. It also induced apoptosis in a limited fraction of cells (10-12%). Flow cytometry data showed that PDT killed mostly G(1)-phase cells, whereas cisplatin killed mostly S-phase cells. This disjointed phase-related effect may account for the favorable effects exerted by combined treatment. CONCLUSIONS: Our findings imply that low doses of cytostatic drugs may be as effective or even more effective than currently used doses if appropriately combined with PDT.


Subject(s)
Breast Neoplasms/drug therapy , Cisplatin/therapeutic use , Indocyanine Green/pharmacology , Photochemotherapy , Antineoplastic Agents/therapeutic use , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Cell Line, Tumor , Cell Survival/drug effects , DNA/biosynthesis , Dose-Response Relationship, Drug , Drug Therapy, Combination , Gene Expression Regulation/drug effects , Glucose/metabolism , Humans , Indocyanine Green/administration & dosage , Protein Biosynthesis/drug effects
2.
FEBS Lett ; 512(1-3): 287-90, 2002 Feb 13.
Article in English | MEDLINE | ID: mdl-11852097

ABSTRACT

Photosensitization of HEC1-B cells with a low concentration of hypericin and doses of light below 10 J/cm(2) caused cell death (apoptosis occurred mainly at doses between 2 and 5 J/cm(2), whereas necrosis prevailed above 6 J/cm(2)). However, pre-exposure of cells to innocuous irradiation (2 J/cm(2)) and successive challenge with a light dose that normally induced apoptosis (5 J/cm(2)) altered the expression of the proteins involved in the regulation of apoptosis, stress response and cell cycle. This change resulted in a significant increase in cell photo-tolerance.


Subject(s)
Carcinoma/drug therapy , Endometrial Neoplasms/drug therapy , Perylene/analogs & derivatives , Perylene/pharmacology , Photochemotherapy , Radiation-Sensitizing Agents/pharmacology , Anthracenes , Apoptosis , Biological Transport , Carcinoma/genetics , Carcinoma/pathology , Endometrial Neoplasms/genetics , Endometrial Neoplasms/pathology , Female , Gene Expression Regulation, Neoplastic , HSP70 Heat-Shock Proteins/genetics , Humans , Necrosis , Perylene/metabolism , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-bcl-2/genetics , Radiation-Sensitizing Agents/metabolism , bcl-2-Associated X Protein , bcl-X Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...